Protagonist Therapeutics, Inc PTGX
2 trading plans running, 24 Form 144 notices for $93.1M
10-Q, 10-K and Form 144What PTGX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Apr 22, 2024 to Sep 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Asif Ali Chief Financial Officer |
Adopted 10b5-1 plan | Jun 30, 2026 | 10-Q Aug 5, 2026 | ||
What the company wroteOn June 30, 2026 , Asif Ali , our Chief Financial Officer , adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to (i) 73,214 shares of the Company’s common stock, (ii) 50% of the net shares issued to Mr. Ali after withholding taxes upon the vesting of restricted stock unit awards representing 21,346 shares of the Company’s common stock, and (iii) 50% of the net shares issued to Mr. Ali after withholding taxes upon the vesting of performance stock unit awards representing 12,800 shares of the Company’s common stock (assuming that such shares underlying performance stock units vest at target amounts) through September 30, 2027 , or such earlier date when all transactions under the trading plan are completed, subject to certain conditions. | |||||
| William Waddill member of our Board |
Adopted 10b5-1 plan | Feb 27, 2026 | 10-Q May 5, 2026 | ||
What the company wroteOn February 27, 2026, William Waddill, a member of our Board, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 27,000 shares of the Company’s common stock through May 31, 2027, or such earlier date when all transactions under the trading plan are completed, subject to certain conditions. | |||||
| Dinesh V. Patel Chief Executive Officer and a member of our Board of Directors |
Adopted 10b5-1 plan | Jan 30, 2026 | 10-Q May 5, 2026 | ||
What the company wroteOn January 30, 2026, Dinesh V. Patel, Ph.D., our Chief Executive Officer and a member of our Board of Directors (the “Board”), adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 300,000 shares of the Company’s common stock through October 9, 2026, or such earlier date when all transactions under the trading plan are completed, subject to certain conditions. | |||||
| William D. Waddill Board |
Adopted 10b5-1 plan | Dec 15, 2024 | 10-K Feb 21, 2025 | ||
What the company wroteOn December 15, 2024, William D. Waddill, a member of our Board, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 24,000 shares of the Company’s common stock through December 31, 2025, or such earlier date when all transactions under the trading plan are completed, subject to certain conditions. | |||||
| Dinesh V. Patel Chief Executive Officer and a member of our Board |
Ended 10b5-1 plan | Jul 15, 2024 | 10-Q Nov 7, 2024 | ||
What the company wroteOn July 15, 2024 , Dinesh V. Patel , our Chief Executive Officer and a member of our Board , terminated a trading plan intended to satisfy Rule 10b5-1(c) which he adopted on April 22, 2024 to sell up to 300,000 shares of the Company’s common stock through July 31, 2025, or such earlier date when all transactions under the trading plan were completed, subject to certain conditions. During the fiscal quarter ended September 30, 2024, no other director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (in each case as defined in Item 408(a) of Regulation S-K). | |||||
| Dinesh V. Patel Chief Executive Officer and member of our Board |
Adopted 10b5-1 plan | Apr 22, 2024 | 10-Q Aug 6, 2024 | ||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Sep 30, 2026 | ASIF ALI Officer |
58,629 | $8.3M |
| Aug 10, 2026 | Dinesh Patel CEO |
225,000 | $33.6M |
| Jun 23, 2026 | WILLIAM WADDILL Director |
9,000 | $1.0M |
| Jun 10, 2026 | WILLIAM WADDILL Director |
9,000 | $953K |
| May 29, 2026 | WILLIAM WADDILL Director |
9,000 | $904K |
| May 12, 2026 | Dinesh Patel CEO |
75,000 | $7.8M |
| May 8, 2026 | BRYAN M & COURTNEY L GIRAUDO RT Director |
11,130 | $1.1M |
| May 7, 2026 | BRYAN GIRAUDO Director |
36,000 | $3.6M |
| May 7, 2026 | BRYAN M & COURTNEY L GIRAUDO RT Director |
12,000 | $1.2M |
| Apr 21, 2026 | Asif Ali Officer |
1,750 | $185K |
| Mar 26, 2026 | HAROLD SELICK Director |
24,000 | $2.5M |
| Mar 26, 2026 | ASIF ALI Officer |
24,765 | $2.6M |
| Mar 26, 2026 | ARTURO MOLINA Officer |
15,000 | $1.6M |
| Mar 24, 2026 | Dinesh Patel CEO |
54,700 | $5.4M |
| Feb 17, 2026 | LEWIS T WILLIAMS Director |
18,000 | $1.5M |
| Feb 6, 2026 | WILLIAM D WADDILL Director |
20,000 | $1.7M |
| Jan 27, 2026 | ASIF ALI Officer |
46,203 | $3.8M |
| Jan 27, 2026 | ARTURO MOLINA Officer |
5,000 | $410K |
| Jan 26, 2026 | ARTURO MOLINA Officer |
5,000 | $411K |
| Jan 23, 2026 | Dinesh Patel CEO |
108,273 | $9.2M |
| Jan 23, 2026 | ARTURO MOLINA Officer |
13,151 | $1.1M |
| Jan 21, 2026 | ARTURO MOLINA MD Officer |
9,514 | $785K |
| Jan 21, 2026 | DINESH V PATEL PH D Officer, Director |
34,438 | $2.8M |
| Jan 21, 2026 | Asif Ali Officer |
8,588 | $708K |
Show the other 16 notices
From the Form 144 XML filed with the SEC, since Jan 21, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PTGX/export.csv") into a cell.